Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma. Cancer. 2008 Aug 15; 113(4):808-14.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Disease-Free Survival
Erlotinib Hydrochloride
Feasibility Studies
Female
Humans
Male
Mesothelioma
Middle Aged
Pleural Neoplasms
Quinazolines
Survival Rate
authors with profiles
Hedy Kindler
Ravi Salgia